Imunon, Inc. Operating Leases, Future Minimum Payments, Due in Three Years
Imunon, Inc. (IMNN) had Operating Leases, Future Minimum Payments, Due in Three Years of $458.00 thousand as of 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-03-29
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $458.00K; Operating Leases, Future Minimum Payments, Due in Three Years as first filed $454.21M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $23.20K; Operating Leases, Future Minimum Payments, Due in Three Years as first filed $291.68K.
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $378.04K.
- 2013-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $297.11K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years | Operating Leases, Future Minimum Payments, Due in Three Years as first filed |
|---|---|---|
| 2017-12-31 | $458.00K 10-K · filed 2019-03-29 | $454.21M 10-K · filed 2018-03-27 |
| 2015-12-31 | $23.20K 10-K · filed 2016-03-30 | $291.68K 10-K · filed 2013-03-18 |
| 2014-12-31 | $378.04K 10-K · filed 2015-03-12 | |
| 2013-12-31 | $297.11K 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |